IHCV has cumulatively invested approximately $135 million in 27 companies across various sectors of the healthcare industry, including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, central nervous system, and other medical areas. The fund pursues a hands-on, personal and informal approach, providing portfolio companies with professional advice, ongoing management support and an extensive network of contacts throughout the global medical and financial arenas. IHCV is open to investment opportunities across a broad spectrum of possibilities in the life sciences field and is not limited by preset policies that define the stage, discipline or the size of investment.